18-Year old patient with anti-epileptic therapy and sudden cardiac death;18-Jährige patientin mit antiepileptischer therapie und kammerflimmern kasuistik eines hochmalignen lqt2-syndroms

Zeitschrift fur Kardiologie

Volumn 92, Issue 9, 2003, Pages 747-753

  Witzenbichler, B ^a   Schulze Bahr, E ^b   Haverkamp, W ^c   Breithardt, G ^b   Sticherling, C ^a   Behrens, S ^d   Schultheiss, H P ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c HUMBOLDT UNIVERSITY   (Germany)

^d VIVANTES HOSPITAL   (Germany)

Author keywords

Epilepsy; Genetics; HERG; Long QT syndrome; Sudden death; Syncope

Indexed keywords

ANTICONVULSIVE AGENT; HERG PROTEIN; POTASSIUM CHANNEL; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANAMNESIS; ANTICONVULSANT THERAPY; ARTICLE; CASE REPORT; CAUSE OF DEATH; CLINICAL FEATURE; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; EPILEPSY; FAMILY HISTORY; FEMALE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; GENOTYPE PHENOTYPE CORRELATION; HEART VENTRICLE FIBRILLATION; HUMAN; LONG QT SYNDROME; MALE; METHODOLOGY; MUTATIONAL ANALYSIS; PREDICTION; PROTEIN POLYMORPHISM; SUDDEN DEATH; UNCONSCIOUSNESS;

ADOLESCENT; ANTICONVULSANTS; CATION TRANSPORT PROTEINS; DEATH, SUDDEN, CARDIAC; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; DNA-BINDING PROTEINS; EPILEPSY; ETHER-A-GO-GO POTASSIUM CHANNELS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; LONG QT SYNDROME; POTASSIUM CHANNELS; POTASSIUM CHANNELS, VOLTAGE-GATED; TRANS-ACTIVATORS; UNCONSCIOUSNESS;

EID: 0141539152     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00392-003-0961-0     Document Type: Article

References (17)

1. Benhorin J, Medina A (1997) Congenital long-QT-syndrome. The New England Journal of Medicine 336:1568
2. Garson JA, Dick II M, Fournier A, Gillette PC, Hamilton R, Kugler JD, Van Hare III GF, Vetter V, Vick III GW (1993) The long-QT-syndrome in children. An International Study of 287 Patients. Circulation 87:1866-1872
3. Haverkamp W, Hoerdt M, Borggrefe M, Breithardt G (1995) Torsade de pointes und QT-syndrome. Med Klin 90:240-245
4. Herman LL, Stoshak M, Rittenberry TJ (1992) Long-QT-syndrome presenting as a seizure. Am J Emerg Med 10:435-438
5. Hurst JW (1998) Naming of the waves in the ECG, with a brief account of their genesis. Circulation 98:1937-1942
6. Khan IA (2002) Clinical and therapeutic aspects of congenital and acquired long-QT-sydrome. Am J Med 112:58-66
7. Moss AJ, Robinson JL, Gressman L, Gillespie R, Zareba W, Schwartz PJ, Vincent GM, Benhorin J, Heilbron EL, Towbin JA, Priori SG, Napolitano C, Zhang L, Medina A, Andrews ML, Timothy K (1999) Comparison of clinical and genetic variables of cardiac events associated with loud noise versus swimming among subjects with the long-QT-syndrome. Am J Cardiol 84:876-879
8. Moss AJ, Zareba W, Hall WJ, Schwartz PJ, Crampton RS, Benhorin J, Vincent GM, Locati EH, Priori SG, Napolitano C, Medina A, Zhang L, Robinson JL, Timothy K, Towbin JA, Andrews ML (2000) Effectiveness and limitations of β-blocker therapy in congenital long-QT-syndrome. Circulation 101:616-623
9. Priori SG, Aliot E, Blomstrom-Lundqvist C, Bossaert L, Breithardt G, Brugada P, Camm JA, Cappato R, Cobbe SM, Di MC, Maron BJ, McKenna WJ, Pedersen AK, Ravens U, Schwartz PJ, Trusz-Gluza M, Vardas P, Wellens HJ, Zipes DP (2002) Task force on sudden cardiac death, european society of cardiology. Europace 4:3-18
10. Priori SG, Bloise R, Crotti L (2001) The long-QT-syndrome. Europace 3:16-27
11. Schwartz PJ, Locati E (1985) Idiopathic long-QT-syndrome: pathogenic mechanisms and therapy. Eur Heart J 6(Suppl D):103-114
12. Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napolitano C, Denjoy I, Guicheney P, Breithardt G, Kearing MT, Towbin JA, Beggs AH, Brink P, Wilde AAM, Toivonen L, Zareba W, Robinson JL, Timothy KW, Corfield V, Wattanasirichaigoon D, Corbett C, Haverkamp W, Schulze-Bahr E, Lehmann MH, Schwartz K, Coumel P, Bloise R (2001) Genotype-phenotype correlation in the long-QT-syndrome. Gene-specific triggers for life-threatening arrhythmias. Circulation 103:89-95
13. Schwartz PM, Moss AJ, Vincent GM, Crampton RS (1993) Diagnostic criteria for the long-QT-syndrome: an update. Circulation 88:782-784
14. Wang Q, Bowles NE, Towbin JA (1998) The molecular basis of long-QT-syndrome and prospects for therapy. Molecular Medicine Today:382-388
15. Wilde AA, Jongbloed RJE, Doevenclans PA, Duren DR, Hauer RN, van Langen IM, van Tintelen JP, Smeets HJ, Meyer H, Geelen JL (1999) Auditory stimuli as a trigger for arrhythmic events differentiates HERG-related (LQT2) patients from KVLQT1-related patients. J Am Coll Cardiol 33:327-332
16. Yan G-X, Antzelevitch C (1998) Cellular basis for the normal T wave and the electrocardiographic manifestations of the long-QT-syndrome. Circulation 98:1928-1936
17. Zhang L, Timothy KW, Vincent M, Lehmann MH, Fox J, Giuli LC, Shen J, Splawki I, Priori SG, Compton SJ, Yanowitz F, Benhorin J, Moss AJ, Schwartz PJ, Robinson JL, Wang Q, Zareba W, Keating MT, Towbin JA, Napolitano C, Medina A (2000) Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT-syndrome. ECG findings identify genotypes. Circulation 102:2849-2855